Assetmark Inc. Purchases 3,948 Shares of Danaher Co. (NYSE:DHR)

Assetmark Inc. grew its stake in Danaher Co. (NYSE:DHR - Free Report) by 6.2% during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 67,234 shares of the conglomerate's stock after purchasing an additional 3,948 shares during the quarter. Assetmark Inc.'s holdings in Danaher were worth $18,692,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of DHR. Vanguard Group Inc. grew its position in shares of Danaher by 7.4% during the 1st quarter. Vanguard Group Inc. now owns 60,107,030 shares of the conglomerate's stock valued at $15,009,928,000 after acquiring an additional 4,163,657 shares during the period. Swedbank AB purchased a new stake in Danaher in the first quarter worth $676,545,000. TD Asset Management Inc raised its stake in shares of Danaher by 99.0% in the second quarter. TD Asset Management Inc now owns 1,358,706 shares of the conglomerate's stock valued at $339,473,000 after buying an additional 675,952 shares during the period. Massachusetts Financial Services Co. MA grew its stake in shares of Danaher by 22.7% during the 2nd quarter. Massachusetts Financial Services Co. MA now owns 3,047,728 shares of the conglomerate's stock worth $761,475,000 after acquiring an additional 563,546 shares during the period. Finally, International Assets Investment Management LLC increased its holdings in Danaher by 40,196.5% in the 3rd quarter. International Assets Investment Management LLC now owns 429,964 shares of the conglomerate's stock worth $119,539,000 after acquiring an additional 428,897 shares during the last quarter. 79.05% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several equities research analysts have commented on the stock. UBS Group dropped their price objective on shares of Danaher from $309.00 to $305.00 and set a "buy" rating on the stock in a report on Wednesday, October 23rd. StockNews.com upgraded shares of Danaher from a "hold" rating to a "buy" rating in a research note on Wednesday. Barclays lowered their target price on shares of Danaher from $285.00 to $275.00 and set an "equal weight" rating on the stock in a report on Wednesday, October 23rd. Raymond James cut their price target on Danaher from $310.00 to $300.00 and set an "outperform" rating for the company in a report on Wednesday, October 23rd. Finally, TD Cowen boosted their price objective on Danaher from $310.00 to $315.00 and gave the company a "buy" rating in a research note on Wednesday, October 23rd. Five analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $287.16.

Danaher Price Performance

Shares of DHR traded down $0.71 during midday trading on Friday, reaching $245.39. The stock had a trading volume of 2,941,170 shares, compared to its average volume of 2,802,560. The company has a market capitalization of $177.24 billion, a price-to-earnings ratio of 46.83, a price-to-earnings-growth ratio of 4.55 and a beta of 0.85. The company has a current ratio of 1.37, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32. Danaher Co. has a 12-month low of $192.35 and a 12-month high of $281.70. The company's 50-day moving average is $264.89 and its 200 day moving average is $260.77.

Danaher (NYSE:DHR - Get Free Report) last released its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 EPS for the quarter, beating the consensus estimate of $1.57 by $0.14. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The company had revenue of $5.80 billion for the quarter, compared to analyst estimates of $5.59 billion. During the same quarter last year, the firm earned $2.02 EPS. The firm's quarterly revenue was up 3.1% compared to the same quarter last year. On average, equities analysts predict that Danaher Co. will post 7.51 EPS for the current fiscal year.

Danaher Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, October 25th. Stockholders of record on Friday, September 27th were issued a $0.27 dividend. This represents a $1.08 annualized dividend and a dividend yield of 0.44%. The ex-dividend date was Friday, September 27th. Danaher's dividend payout ratio is 20.61%.

Insider Buying and Selling

In other news, SVP Georgeann Couchara sold 952 shares of the company's stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $268.37, for a total transaction of $255,488.24. Following the completion of the transaction, the senior vice president now directly owns 4,212 shares of the company's stock, valued at approximately $1,130,374.44. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 11.10% of the stock is owned by insiders.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.